Actively Recruiting

Age: 1Minute - 23Months
All Genders
NCT06555809

Evaluation of Artesunate in Infants Being Treated for Severe Malaria

Led by Amivas Inc. · Updated on 2024-12-10

15

Participants Needed

1

Research Sites

281 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is essentially a laboratory study that is an addendum to an ongoing prospective Phase 4 multicenter observational study titled: "Safety and Efficacy of Artesunate in Pregnant Women and Infants (ARTEMUM)" being conducted in France. Infants, the parents of whom provided consent to have data collected from their child as part of the ARTEMUM study, will have an additional blood sample collected when other standard of care blood specimens are collected during the 2-day period after the start of intravenous (IV) artesunate treatment. A maximum of 4 samples will be taken and plasma will be isolated and stored frozen until analysis for plasma artesunate and dihydroartemisinin (DHA) concentrations. Red blood cells will also be frozen for further analysis (for example Kelch-13 mutations). In addition, a standard of care blood sample will be collected approximately one month post treatment for clinical laboratory tests.

CONDITIONS

Official Title

Evaluation of Artesunate in Infants Being Treated for Severe Malaria

Who Can Participate

Age: 1Minute - 23Months
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Parental consent provided to the ARTEMUM Study
  • Parental consent provided to participate in this PK Laboratory Study
  • Infants younger than 2 years of age with malaria confirmed by PCR, thin or thick smear, or rapid diagnostic test
  • Treated with at least one dose of intravenous artesunate
Not Eligible

You will not qualify if you...

  • Hemoglobin less than 7.0 g/dL at the time of additional blood sample collection for pharmacokinetic assessment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hôpital Cochin Port Royal

Paris, France, 75014

Actively Recruiting

Loading map...

Research Team

B

Bernadette Tock

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Evaluation of Artesunate in Infants Being Treated for Severe Malaria | DecenTrialz